Literature DB >> 26085453

Polyunsaturated Fat Intake Estimated by Circulating Biomarkers and Risk of Cardiovascular Disease and All-Cause Mortality in a Population-Based Cohort of 60-Year-Old Men and Women.

Matti Marklund1, Karin Leander1, Max Vikström1, Federica Laguzzi1, Bruna Gigante1, Per Sjögren1, Tommy Cederholm1, Ulf de Faire1, Mai-Lis Hellénius1, Ulf Risérus2.   

Abstract

BACKGROUND: High intake of polyunsaturated fatty acids (PUFAs) may reduce the risk of cardiovascular disease (CVD) and mortality. Large, prospective studies including both sexes and circulating PUFAs as dietary biomarkers are needed. We investigated sex-specific associations of the major dietary PUFAs, eicosapentaenoic acid, docohexaenoic acid, linoleic acid, and α-linolenic acid, with incident CVD and all-cause mortality in a population-based cohort. METHODS AND
RESULTS: PUFAs in serum cholesterol esters were measured at baseline in 60-year-old Swedish women (n=2193) and men (n=2039). With the use of national registers, 484 incident CVD events (294 men and 190 women) and 456 all-cause deaths (265 men and 191 women) were identified during follow-up (median, 14.5 years) in individuals without prior CVD at baseline. Associations of PUFAs with CVD and mortality were evaluated with Cox proportional hazard models. In multivariable-adjusted models, 1-SD increases in eicosapentaenoic acid and docohexaenoic acid were associated with lower risk of incident CVD among women (hazard ratio [HR], 0.79 [95% confidence interval (CI), 0.64-0.97] and 0.74 [95% CI, 0.61-0.89], respectively). α-Linolenic acid was associated with moderately increased CVD risk in women (HR, 1.16; 95% CI, 1.02-1.32). Inverse associations with all-cause mortality were observed for eicosapentaenoic acid and docohexaenoic acid among all participants (HR, 0.81 [95% CI, 0.72-0.91] and 0.80 [95% CI, 0.72-0.89], respectively) and for linoleic acid in men (HR, 0.73; 95% CI, 0.64-0.83).
CONCLUSIONS: Serum linoleic acid and very-long-chain n-3 PUFAs, partly reflecting vegetable oil and fish intake, respectively, were inversely associated with all-cause mortality. Inverse associations of eicosapentaenoic acid and docohexaenoic acid with incident CVD were observed only in women.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  biological markers; cardiovascular diseases; cohort studies; epidemiology; fatty acids; mortality

Mesh:

Substances:

Year:  2015        PMID: 26085453     DOI: 10.1161/CIRCULATIONAHA.115.015607

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies.

Authors:  Jun Li; Marta Guasch-Ferré; Yanping Li; Frank B Hu
Journal:  Am J Clin Nutr       Date:  2020-07-01       Impact factor: 7.045

2.  Red blood cell polyunsaturated fatty acids and mortality in the Women's Health Initiative Memory Study.

Authors:  William S Harris; Juhua Luo; James V Pottala; Mark A Espeland; Karen L Margolis; Joann E Manson; Lu Wang; Theodore M Brasky; Jennifer G Robinson
Journal:  J Clin Lipidol       Date:  2017-01-12       Impact factor: 4.766

3.  Plasma n-6 Fatty Acid Levels Are Associated With CD4 Cell Counts, Hospitalization, and Mortality in HIV-Infected Patients.

Authors:  Edmond K Kabagambe; Amara E Ezeamama; David Guwatudde; Hannia Campos; Wafaie Fawzi
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

4.  Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome.

Authors:  Shusuke Yagi; Ken-ichi Aihara; Daiju Fukuda; Akira Takashima; Mika Bando; Tomoya Hara; Sachiko Nishimoto; Takayuki Ise; Kenya Kusunose; Koji Yamaguchi; Takeshi Tobiume; Takashi Iwase; Hirotsugu Yamada; Takeshi Soeki; Tetsuzo Wakatsuki; Michio Shimabukuro; Masashi Akaike; Masataka Sata
Journal:  Nutr J       Date:  2015-10-29       Impact factor: 3.271

5.  N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis.

Authors:  Guo-Chong Chen; Jing Yang; Manfred Eggersdorfer; Weiguo Zhang; Li-Qiang Qin
Journal:  Sci Rep       Date:  2016-06-16       Impact factor: 4.379

6.  Serum Fatty Acids, Desaturase Activities and Abdominal Obesity - A Population-Based Study of 60-Year Old Men and Women.

Authors:  Zayed D Alsharari; Ulf Risérus; Karin Leander; Per Sjögren; Axel C Carlsson; Max Vikström; Federica Laguzzi; Bruna Gigante; Tommy Cederholm; Ulf De Faire; Mai-Lis Hellénius; Matti Marklund
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

7.  Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: Results from the Progredir Cohort.

Authors:  Silvia M Titan; Gabriela Venturini; Kallyandra Padilha; Alessandra C Goulart; Paulo A Lotufo; Isabela J Bensenor; Jose E Krieger; Ravi I Thadhani; Eugene P Rhee; Alexandre C Pereira
Journal:  PLoS One       Date:  2019-03-18       Impact factor: 3.240

8.  Dietary and Circulating Long-Chain Omega-3 Polyunsaturated Fatty Acids and Mortality Risk After Myocardial Infarction: A Long-Term Follow-Up of the Alpha Omega Cohort.

Authors:  Kamalita Pertiwi; Leanne K Küpers; Janette de Goede; Peter L Zock; Daan Kromhout; Johanna M Geleijnse
Journal:  J Am Heart Assoc       Date:  2021-11-30       Impact factor: 6.106

9.  Effect of Dietary Counseling on a Comprehensive Metabolic Profile from Childhood to Adulthood.

Authors:  Miia Lehtovirta; Katja Pahkala; Harri Niinikoski; Antti J Kangas; Pasi Soininen; Hanna Lagström; Jorma S A Viikari; Tapani Rönnemaa; Antti Jula; Mika Ala-Korpela; Peter Würtz; Olli T Raitakari
Journal:  J Pediatr       Date:  2018-02-01       Impact factor: 4.406

10.  Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study.

Authors:  William S Harris; Nathan L Tintle; Mark R Etherton; Ramachandran S Vasan
Journal:  J Clin Lipidol       Date:  2018-03-02       Impact factor: 4.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.